As companies strive to make their sequencing capabilities longer, more accurate, faster, and cheaper, the detection of low frequency DNA mutations remains one limitation that no one has overcome. The young start-up, TwinStrand Biosciences, a spin out of the University of Washington, is hoping to crack that nut with their duplex sequencing technology . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge